What is Zonisamide?

Zonisamide is an anticonvulsant medication primarily used to treat epilepsy and sometimes prescribed off-label for migraine prevention, neuropathic pain, and weight management. It works by stabilizing neuronal activity through sodium and calcium channel modulation, as well as by influencing GABAergic and dopaminergic systems.

Zonulin is a protein that opens intercellular tight junctions in the gut lining (the connections between epithelial cells that make up the gastrointestinal lining). Zonulin increases intestinal permeability in the jejunum and ileum and is considered a biomarker for barrier permeability.

Zonulin is a protein that plays a key role in regulating the permeability of the tight junctions between cells in the lining of the small intestine. These tight junctions are like gates that control what substances can pass from the gut into the bloodstream.

When zonulin levels are balanced, the intestinal barrier remains tight and selective. However, when zonulin levels increase, the intestinal barrier becomes more "leaky," allowing larger molecules like undigested food particles, toxins, and microbes to cross into the bloodstream. This condition is commonly referred to as increased intestinal permeability, or more informally, leaky gut.

Measuring zonulin in stool offers a non-invasive way to assess the integrity of the gut barrier, particularly in the small intestine.

Zonulin, a protein that regulates the permeability of the intestinal lining, plays a key role in maintaining the gut barrier. It breaks down tight junctions between the cells in the gastrointestinal (GI) tract, which are essential for protecting the body from external threats. When these tight junctions are compromised, it results in increased intestinal permeability, often referred to as "leaky gut." This weakened barrier makes the body more susceptible to food antigens, toxins, and harmful microbes, leading to elevated inflammation.

High plasma zonulin levels have been associated with a variety of health conditions, including celiac disease, autoimmune disorders, type 1 diabetes, multiple sclerosis, and rheumatoid arthritis. Studies have shown that patients with active celiac disease have higher zonulin levels compared to those without the condition. Additionally, elevated zonulin levels may appear 2 to 5 years before the onset of autoimmune diseases, diabetes, or allergies, suggesting zonulin could serve as an early marker for these disease processes.

Zonulin is a protein that opens intercellular tight junctions in the gut lining (the connections between epithelial cells that make up the gastrointestinal lining). Zonulin increases intestinal permeability in the jejunum and ileum and is considered a biomarker for barrier permeability.

Zonulin is a protein modulator of intestinal tight junctions and is used to assess intestinal permeability. It can be used for assessing impaired gut barrier function for several autoimmune and metabolic conditions including celiac disease, type 1 diabetes and insulin resistance.

This test is for research use only. Genova will not provide support on interpreting the test results. This test does not detect zonulin. The Scheffler paper suggests that the IDK kit may detect a zonulin family peptide, such as properdin. Genova’s unpublished data demonstrated that the current IDK kit results were associated with stool inflammation biomarkers and an inflammation-associated dysbiosis profile. The performance characteristics of Zonulin Family Peptide have been verified by Genova Diagnostics, Inc. The assay has not been cleared by the U.S. Food and Drug Administration.

Zonulin is a marker of intestinal permeability, otherwise known as leaky gut. If a person has elevated Zonulin levels, the normal regulation of the tight junctions is compromised. 

Zonulin is a protein that is synthesized in intestinal cells and liver cells. It is a key biomarker for intestinal permeability and is the only regulator of intestinal permeability that is reversible.

What is intestinal permeability?

Intestinal permeability, often referred to as "leaky gut," is a condition where the lining of the small intestine becomes damaged, causing undigested food particles, toxins, and bacteria to leak through the intestinal wall into the bloodstream. Normally, the gut lining acts as a barrier, selectively allowing nutrients to pass through while keeping harmful substances out. When this barrier is compromised, it can lead to inflammation and trigger immune responses, potentially contributing to various health issues such as food sensitivities, digestive problems, and even autoimmune diseases.

The Zucchini marker measures IgG antibodies to proteins found in zucchini. Results are reported as none detected, very low, low, moderate, or high. These levels reflect immune exposure and recognition rather than a true zucchini allergy. Interpretation should consider preparation method, portion size, and overall digestive tolerance.

Elevated antibody levels can be clinically significant — while the antibodies themselves don’t destroy anything, they do trigger an inflammatory response that can cause significant destruction of tissue and resulting symptoms. This response is not necessarily dependent on antibody levels. However, an equivocal result may mean you are just beginning to exhibit an immune reaction, so this is an important time to take measures to support the body in damping immune reactivity.